Guardian Pharmacy Services, Inc.
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.28B | 1.23B | 1.17B | 1.12B | 1.07B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.28B | 1.23B | 1.17B | 1.12B | 1.07B |
| Cost of Revenue | 1.03B | 984.04M | 939.06M | 896.10M | 860.46M |
| Gross Profit | 253.62M | 244.37M | 231.85M | 223.16M | 212.19M |
| SG&A Expenses | 306.73M | 300.35M | 270.05M | 163.08M | 143.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.34B | 1.28B | 1.21B | 1.06B | 1.00B |
| Operating Income | -53.11M | -55.98M | -38.20M | 60.08M | 68.37M |
| Income Before Tax | -60.47M | -69.26M | -70.93M | 27.72M | 36.32M |
| Income Tax Expenses | 8.39M | 4.56M | 176.00K | -- | -- |
| Earnings from Continuing Operations | -68.86 | -73.82 | -71.10 | 27.72 | 36.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -11.77M | -16.25M | -18.90M | -16.37M | -14.12M |
| Net Income | -80.63M | -90.07M | -90.00M | 11.35M | 22.20M |
| EBIT | -53.11M | -55.98M | -38.20M | 60.08M | 68.37M |
| EBITDA | -32.88M | -36.27M | -18.93M | 79.00M | 86.90M |
| EPS Basic | -1.65 | -1.80 | -2.00 | -- | -- |
| Normalized Basic EPS | -0.84 | -0.98 | -1.19 | -- | -- |
| EPS Diluted | -1.66 | -1.81 | -2.00 | -- | -- |
| Normalized Diluted EPS | -0.85 | -0.98 | -1.19 | -- | -- |
| Average Basic Shares Outstanding | 185.23M | 123.19M | 61.14M | -- | -- |
| Average Diluted Shares Outstanding | 186.78M | 123.87M | 61.14M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -15.27% | -21.58% | -32.71% | 208.44% | 177.43% |